Treatment with a mineralocorticoid receptor blocker esaxerenone on top of the first-line therapy: promise in uncontrolled hypertension.

Autor: Mukoyama M; Department of Nephrology, Omuta Tenryo Hospital, Omuta, Fukuoka, Japan. mmuko@kumamoto-u.ac.jp.
Jazyk: angličtina
Zdroj: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2024 Dec; Vol. 47 (12), pp. 3492-3493. Date of Electronic Publication: 2024 Oct 17.
DOI: 10.1038/s41440-024-01959-2
Abstrakt: Competing Interests: Compliance with ethical standards. Conflict of interest: The author declares no competing interests.
Databáze: MEDLINE